Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NR3C2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04912011
What this trial is testing

Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.

Who this might be right for
COVID-19 Pneumonia
Pomeranian Medical University Szczecin 50
Testing effectiveness (Phase 2)Ended earlyNCT06818305
What this trial is testing

Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)Nephrectomy+1 more
Jinling Hospital, China 10
Post-approval studies (Phase 4)Looking for participantsNCT07026539
What this trial is testing

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease Due to Type 2 Diabetes MellitusCardiovascular Diseases
University of Aarhus 80
Early research (Phase 1)Study completedNCT03450759
What this trial is testing

A Single Oral Dose Study to Evaluate Four Different Formulations of AZD9977 and the Effect of Food in Healthy Male Subjects

Who this might be right for
Healthy Volunteers
AstraZeneca 13
Not applicableStudy completedNCT04903717
What this trial is testing

Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists

Who this might be right for
Heart Failure With Reduced Ejection Fraction
Yale University 1,210
Testing effectiveness (Phase 2)Ended earlyNCT00647192
What this trial is testing

EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion

Who this might be right for
Atrial Fibrillation
University Hospital, Saarland 38
Not applicableStudy completedNCT00646828
What this trial is testing

Cardiovascular Evaluation of Adult PHA 1 Patients

Who this might be right for
Pseudohypoaldosteronism Type 1
Assistance Publique - Hôpitaux de Paris 98
Testing effectiveness (Phase 2)Looking for participantsNCT07483177
What this trial is testing

HEART: Pilot Randomized Controlled Trial

Who this might be right for
Thoracic Aortic Aneurysm
Mayo Clinic 50
Not applicableWithdrawnNCT05806970
What this trial is testing

Email Nudges to Improve GDMT (MRA) Adherence in Heart Failure

Who this might be right for
Heart Failure With Reduced Ejection Fraction
University of California, Los Angeles
Not applicableStudy completedNCT03174288
What this trial is testing

The Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University of Virginia 32
Post-approval studies (Phase 4)UnknownNCT05814770
What this trial is testing

Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism

Who this might be right for
Primary AldosteronismHypertension
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 96
Not applicableStudy completedNCT04168073
What this trial is testing

Sodium Diet Effect on Aldosterone and Urinary RNA (SALTY)

Who this might be right for
Healthy
University of Michigan 21
Testing effectiveness (Phase 2)Looking for participantsNCT07029503
What this trial is testing

Swedish Cardiac And Renal Failure Study-1

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionChronic Kidney Disease
Karolinska Institutet 40
Large-scale testing (Phase 3)Study completedNCT02585843
What this trial is testing

Mineralocorticoid Receptor Antagonists (MRA) in Heart Failure (HF) and Loop Diuretic Resistance

Who this might be right for
Heart Failure
Columbia University 20
Early research (Phase 1)Study completedNCT03804645
What this trial is testing

Assess the Reaction of Body for Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male Subjects

Who this might be right for
Heart Failure
AstraZeneca 12
Very early researchActive Not RecruitingNCT07345845
What this trial is testing

MR and Inflammation After Preeclampsia

Who this might be right for
PreeclampsiaPreeclampsia Postpartum
Anna Stanhewicz, PhD 40
Very early researchLooking for participantsNCT06749418
What this trial is testing

Vascular Effects of High-Salt After Preeclampsia

Who this might be right for
PreeclampsiaPreeclampsia Postpartum
Anna Stanhewicz, PhD 40
Testing effectiveness (Phase 2)Looking for participantsNCT06655480
What this trial is testing

Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF

Who this might be right for
HFpEFLVDDMyocardial Fibrosis
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50
Post-approval studies (Phase 4)Study completedNCT06094920
What this trial is testing

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

Who this might be right for
Diabetes Mellitus Type 2 With ProteinuriaDiabetes Mellitus, Type 2Diabetes Mellitus+10 more
University Medical Center Groningen 12
Testing effectiveness (Phase 2)Looking for participantsNCT05198791
What this trial is testing

Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries.

Who this might be right for
Myocardial Infarction, AcuteMyocardial Infarction With Nonobstructive Coronary ArteriesMyocardial Injury
NHS National Waiting Times Centre Board 400
Next Page